Where: The Keck Center (Room 100)
With the conclusion of last December’s International Summit on Human Gene Editing, the second component of the Human Gene Editing Initiative is now moving forward: a comprehensive study of the scientific underpinnings of human gene-editing technologies, their potential use in biomedical research and medicine — including human germline editing — and the clinical, ethical, legal, and social implications of their use.
This study is being conducted by a multidisciplinary committee of experts, which began its information-gathering process at the summit. Over the next year, it will perform its own independent and in-depth review of the science and policy of human gene editing by reviewing the literature and holding data-gathering meetings in the U.S. and abroad to solicit broad input from researchers, clinicians, policymakers, and the public. The committee will also monitor in real-time the latest scientific achievements of importance in this rapidly developing field. Finally, while informed by the statement issued by the organizing committee for the international summit, the study committee will have broad discretion to arrive at its own findings and conclusions, which will be released in a peer-reviewed consensus report. Expected to be completed in late 2016, the report will represent the official views of NAS and NAM.